Cooper Companies | COO

Stock Price
68.09
Daily Change
0.09 0.13%
Monthly
-0.04%
Yearly
-36.13%
Q3 Forecast
67.52

Peers Price Chg Day Year Date
Abbott 132.94 0.13 0.10% 16.68% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Haemonetics 54.38 0.30 0.55% -25.75% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Novartis 129.82 1.34 1.04% 11.22% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
ResMed 277.05 3.24 1.18% 13.23% Sep/05
STAAR Surgical 27.94 0.16 0.58% -10.22% Sep/05
Steris 245.30 1.91 0.78% 2.42% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Bausch Health Companies 10.18 0.20 2.00% 20.90% Sep/05
Dentsply International 14.62 0.29 2.02% -42.75% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05

Cooper Companies traded at $68.09 this Friday September 5th, increasing $0.09 or 0.13 percent since the previous trading session. Looking back, over the last four weeks, Cooper Companies gained 0.04 percent. Over the last 12 months, its price fell by 36.13 percent. Looking ahead, we forecast Cooper Companies to be priced at 67.52 by the end of this quarter and at 65.86 in one year, according to Trading Economics global macro models projections and analysts expectations.

The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.